Therefore, it is easy to understand the fact that the CRP/albumin ratio is considered a significant prognostic factor for advanced-stage ovarian cancer patients, with a higher value of this parameter being considered as a sign of the biological decline in ovarian cancer patients [17]. The gene discussed is CRP; the disease is ovarian carcinoma.